5 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 29957545 | Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA). | 2018 Aug | 2 |
2 | 25924475 | [The in vitro HAART pharmacodynamics study with dolutegravir as the "anchor"]. | 2015 Jan | 1 |
3 | 25397500 | Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses. | 2014 | 1 |
4 | 21381981 | S/GSK1349572, a new integrase inhibitor for the treatment of HIV: promises and challenges. | 2011 Apr | 2 |
5 | 22101373 | Implications of integrase inhibitors for HIV-infected transplantation recipients: raltegravir and dolutegravir (S/GSK 1349572). | 2011 | 2 |